• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/135 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Patent holdings for IPC class C07D 295/135

Total number of patents in this class: 436

10-year publication summary

28
25
30
33
28
30
25
19
17
11
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Richter Gedeon Nyrt.
1702
15
University of Pittsburgh - Of the Commonwealth System of Higher Education
3304
13
Gen1e Lifesciences Inc.
31
11
ChemoCentryx, Inc.
361
8
The Regents of the University of California
20745
7
PIMCO 2664 Limited
20
7
The Arizona Board of Regents on Behalf of the University of Arizona
2298
6
Omeros Corporation
305
6
The United States Government AS represented by The Department of Veterans Affairs
1329
6
The United States of America as represented by the Department of Veterans Affairs
298
6
Dana-Farber Cancer Institute, Inc.
2664
5
Neoculi Pty Ltd
18
5
Acelot, Inc.
16
5
Merck Sharp & Dohme LLC
3734
5
AbbVie Deutschland GmbH & Co. KG
258
4
Curza Global, LLC
28
4
University of Utah Research Foundation
1862
4
Lunella Biotech, Inc.
102
4
Hoffmann-La Roche Inc.
3793
3
AstraZeneca AB
2814
3
Other owners 309